A nurse has successfully initiated an IV infusion as ordered for a client. After securing the IV catheter and tubing, which of these actions should the nurse take next?
a. Document the IV insertion in the nurse's notes.
b. Start an IV flow sheet.
c. Prepare the next bag of solution for infusion, and leave it at the client's bedside.
d. Place a label with the date and time of insertion and the size and gauge of catheter on the dressing.
D
The final step in the insertion of an IV catheter is to place a label with the date and time of insertion and the size and gauge of catheter on the dressing. When client care is complete, document in the medical record.
You might also like to view...
The nurse is examining a male client's genitalia and notes the scrotum is asymmetric. The left side hangs lower than the right side. Based on this data, which action by the nurse is the most appropriate?
1. Reassess after increasing the temperature in the room. 2. Report the finding to the healthcare provider. 3. Consider this a normal finding and proceed with palpation of the scrotum. 4. Ask if the client if has noticed this before.
During an assessment the nurse learns that a patient has an alteration in the sense of smell. What should the nurse consider as causes of this alteration?
Select all that apply. 1. rhinoplasty 2. zinc deficiency 3. deviated septum 4. olfactory nerve damage 5. chronic inflammation of the nose
A drainage system is used in a post-mastectomy client for the expected bloody drainage
Which is used to drain a post-mastectomy wound? A) EnzySurge B) Hemovac C) VariCare D) Fibracol
Martha, a patient suffering from hypothyroidism, has just found out that she is pregnant. She contacts Dr. Hudson to find out whether she should continue her thyroid hormone replacement therapy during her pregnancy. Which of the following instructions is Dr. Hudson most likely to give Martha?
A. Discontinue treatment because the thyroid hormones administered to pregnant women readily cross the placental barrier and affect fetal development. B. Discontinue treatment until the third trimester, when there is no longer a risk of the drug affecting fetal development. C. Continue the treatment at half the dosage as the growing fetus may be very sensitive to the effects of the drug. D. Continue treatment as usual because the thyroid hormones administered to pregnant women do not readily cross the placental barrier to affect fetal development.